InvestSMART

Biome Australia Limited (ASX:BIO)

ALERT: Price-sensitive ASX Announcement for BIO
Current share price for BIO : $0.405 0.14 (52.83%)+
Announcement
Release
29 Jul 2026 8:40AM
Price at Release
$0.265
Full Release
download
Summary
Biome Australia Limited reported strong financial performance for the quarter ended 30 June 2026, marking a record year in terms of trading and financial performance. The company achieved a 30% increase in annual sales revenue compared to the previous financial year, driven by the high demand for its Activated Probiotics and Activated Therapeutics ranges. Significant milestones included reaching the number one spot for probiotic products in Australian pharmacies and surpassing 100,000 units in consumer sell-through. The quarter saw a net operating cash inflow of $708k, and a cash balance increase to $3.6m. Biome continued to invest in proprietary intellectual property, including a patent application for a new probiotic strain. The company also signed an onshore manufacturing agreement and reduced its net debt by $1.0m. Biome's quarterly activities demonstrate its strategic growth and operational efficiency, setting a solid foundation for future expansion.
Key Points
  • Record annual sales revenue of $23.9m for FY26, up 30% from FY25.
  • Activated Probiotics became the top probiotic product in Australian pharmacies.
  • Consumer sell-through surpassed 100,000 units for the first time in June 2026.
  • Net operating cash inflow of $708k for the quarter.
  • Cash balance increased to $3.6m at 30 June 2026.
  • Debt reduced by $1.0m to $1.9m drawn at 30 June 2026.
  • Investment in proprietary intellectual property including a new patent.
  • Signed onshore manufacturing agreement with Specialty Probiotics Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.